To confirm that this FoxO1-zDHHC4-CD36 S-acylation axis was of relevance in T2D in vivo, we investigated the effects of FoxO1 genetic silencing or pharmacological inhibition in diabetic mice. Here, CD36 is linked to type 2 diabetes mellitus.